Jimtash, you state that Radient should rethink their strategy.
AMDL/Radient has been attempting to market DR70 for years and years. In 2001, they signed multiple distributors for the test in the USA, Canada and the UK. The test failed because of multiple false positives. The test was not viable.
The CEO at the time decided the lack of FDA approval was the main problem with marketing so for 6 more years, they pursued FDA approval as a cancer test. Multiple rejections by the FDA finally resulted in applying for monitoring of CRC. The FDA cleared the test for that purpose only and in addition, they required that the CEA test still be run along with the DR70.
IMO, Radient cheated in their clinical trials. They screened the control group and eliminated those with infections, intestinal problems, heart problems and other conditions that would lead to a high FDP level. Just read the clinical study, it is there is black and white. IMO, it is a wonder the FDA even cleared the test.
JimTash, DR70 is a bad test with lots of false positives. If you think management has made mistakes and it could have been marketed better, what would you have done?
After the Chinese bailed with Jade, all MacLellan had left was DR70. What does he do at that point? It is obvious that he decided to lie, cheat and steal money from investors. Would you have just hung it up and called it quits at that point? IMO, that is exactly what he should have done.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
